Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

An Open-label, Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of Sublingually Administered (S)-Ketamine Oral Solution in Healthy Participants

To see complete record on, please visit this link

Id: NCT04282746

Organisation Name: Janssen Research & Development, LLC

Overal Status: Completed

Start Date: February 18, 2020

Last Update: September 16, 2021

Lead Sponsor: Janssen Research & Development, LLC

Brief Summary: The purpose of this study is to characterize the plasma pharmacokinetic (PK) profile following the single ascending dose (SAD) levels of an (S)-ketamine oral solution for sublingual administration in healthy participants.

  • Healthy

Total execution time in seconds: 0.20811200141907